StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
H.C. Wainwright Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
June 5, 2026 8:17 AM
H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating and $510.00 price target on Alnylam Pharmaceuticals (NASDAQ: ALNY).The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
